Equity Profile
Pre-Earnings Brief
Avantor, Inc. is a key player in the health care sector, specializing in life sciences tools and services....
Earnings Per Share (EPS)
EPS is a crucial indicator of the company's profitability and is closely watched by investors.
Revenue Growth
While specific revenue estimates are not available, growth in this area can signal strong demand for Avantor's products.
1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
2Q
EPS Beat Rate
63%
Avg EPS Surprise
+2.25%
Avg Stock Reaction
-9.02%
In Q1-2026, Avantor reported an EPS of $0.17, slightly beating expectations of $0.16. However, the stock saw a minor decline of 0.13% the following day, indicating mixed investor sentiment.
Management Promises & Guidance
Investors are cautiously optimistic about Avantor's upcoming earnings, given its history of beating EPS estimates. However, the lack of revenue guidance adds uncertainty.
Bull Case
If Avantor can deliver strong EPS and show signs of revenue growth, it could boost investor confidence and drive the stock higher.
Bear Case
Conversely, if the company fails to meet EPS expectations or shows weak revenue growth, it could lead to a significant drop in the stock price.
Earnings Per Share (EPS)
Expected to be around $0.17.EPS is a crucial indicator of the company's profitability and is closely watched by investors.
Revenue Growth
N/AWhile specific revenue estimates are not available, growth in this area can signal strong demand for Avantor's products.
Market Reaction
N/AUnderstanding how the stock typically reacts to earnings surprises can provide context for potential volatility.
Expectations
The print will turn on these two things.
Q1
What will be the EPS for Q2-2026?
EPS is a key indicator of profitability, and any deviation from expectations could significantly impact stock performance.
Q2
Will there be any guidance on revenue growth?
Revenue growth is critical for assessing demand for Avantor's products, and guidance can provide insight into future performance.
Edge
Why consensus could be wrong
The consensus may underestimate Avantor's ability to innovate and capture market share, especially in a growing life sciences sector.
Supporting Evidence
Historically, Avantor has beaten EPS estimates 63% of the time.
Options pricing suggests a higher expected move than historical averages, indicating potential for a surprise.
Recent trends in the life sciences sector indicate increasing demand for Avantor's products.
Key Risk
If the EPS significantly exceeds $0.17, it could challenge the current bearish sentiment.
Edge
Pre-commit to what would confirm each case.
Investors are weighing the potential for growth against the backdrop of recent earnings surprises and market conditions.
Bull Confirmed If
An EPS of $0.18 or higher would confirm strong operational performance.
Bear Confirmed If
An EPS below $0.15 would raise concerns about profitability.
Pre-Earnings Positioning
Implied Move
±19.3%
Historical Avg
±12.1%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±19.3% while AVTR has averaged ±12.1% over the last 8 prints — setup is pricing rich.
ATM IV
0.7%
30d HV
34.6%
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Avantor beats expectations, history suggests a potential average move of +3.4%, confirming a positive outlook.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors await further clarity.
Miss
A miss could lead to a decline, with history indicating an average drop of -18.42% in similar scenarios.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Curbline Properties Corp.